
(AGENPARL) – SILVER SPRING lun 12 giugno 2023 AFSTYLA, Antihemophilic Factor (Recombinant), Single Chain, is a recombinant, antihemophilic factor indicated in adults and children with hemophilia A (congenital Factor VIII deficiency) for:
• On-demand treatment and control of bleeding episodes,
• Routine prophylaxis to reduce the frequency of bleeding episodes,
• Perioperative management of bleeding.
Fonte/Source: http://www.fda.gov/vaccines-blood-biologics/approved-blood-products/afstyla